Extraction, Derivatization and Ultra-Sensitive GC/Triple Quadrupole Analysis of Estrone and Estradiol in Human Serum

Significance of the Topic

Estrone (E1) and estradiol (E2) are the primary endogenous estrogens in both females and males. Accurate quantification of these hormones at ultra-low concentrations in human serum is critical for endocrine research, clinical monitoring of hormone therapies, and understanding pathophysiological conditions related to estrogen imbalance.

Objectives and Overview of the Study

This technical overview describes an end-to-end workflow for the extraction, derivatization, and ultra-sensitive analysis of E1 and E2 in human serum. Key aims include the implementation of a solid phase extraction (SPE) protocol, an optimized derivatization strategy, and gas chromatography–triple quadrupole mass spectrometry (GC–QqQ MS) parameters to achieve low-pg/mL detection limits.

Methodology and Instrumentation

• Sample Preparation
  1 mL of 0.5 M sodium acetate buffer, 0.5 mL serum/plasma, and 50 µL of deuterated internal standards (d4-E1 and d5-E2) were mixed and extracted with 1-chlorobutane. Following vortexing and centrifugation, the organic layer was collected.
• Solid Phase Extraction
  Silica SPE cartridges were conditioned sequentially with ethyl acetate, hexanes, and 1-chlorobutane. The sample extract was applied by gravity, washed with EtOAc/hexanes (1:9), and eluted twice with EtOAc/hexanes (1:1). Eluates were evaporated to dryness.
• Derivatization
  Dried extracts were treated with 10 % pyridine in ethyl acetate and 1 % pentafluorobenzoyl chloride reagent. The reaction was incubated at 60 °C for 30 minutes, followed by aqueous bicarbonate workup, hexane extraction, and final reconstitution in dodecane for injection.
• GC/Triple Quadrupole MS
  Instrumentation: Agilent GC coupled to a triple quadrupole MS in negative chemical ionization (NCI) mode with ammonia reagent gas.
  Column: DB-17ht (5 m×250 mm, 0.15 µm) or secondary short column (15 m×250 mm, 0.15 µm).
  Oven: 210 °C (0.9 min) → 290 °C at 35 °C/min → 305 °C at 2 °C/min (total run ≈10.7 min).
  MRM Transitions: E1 (m/z 464→400), E2 (660→596) and corresponding ISTDs with wide resolutions, dwell time 50 ms.

Main Results and Discussion

The workflow demonstrated reproducible detection of E1 and E2 at levels down to 1 pg/mL, with high specificity under NCI conditions. SPE cleanup provided robust matrix removal, while pentafluorobenzoyl derivatives enhanced ionization efficiency. The GC/QqQ method achieved sharp peaks, consistent retention times, and low background noise, enabling precise quantification in clinical serum samples.

Benefits and Practical Applications

• Clinical Research: Hormone profiling for patients on aromatase inhibitors or with endocrine disorders.
• Pharmacokinetics: Monitoring steroidal drug metabolism and biomarker studies.
• Quality Assurance: High-throughput screening in regulated laboratories thanks to a streamlined SPE/derivatization workflow.

Future Trends and Potential Applications

Further advancements may include automation of SPE and derivatization steps, miniaturization for high-throughput platforms, expansion to other estrogen metabolites, and integration with high-resolution MS for untargeted profiling.

Conclusion

A complete SPE–derivatization–GC/QqQ MS workflow has been established for ultra-sensitive quantification of estrone and estradiol in human serum. This method offers rapid throughput, excellent sensitivity, and robustness suitable for clinical and research laboratories focused on low-level estrogen analysis.

References

1. Churley M., Macherone A., Highly Repeatable Ultra Low Detection of Estradiol Using Triple Quadrupole GC/MS in NCI Mode; Agilent Technologies Application Note 5990-5513EN (2010).
2. Macherone A., Churley M., White R., Ultralow detection of estrogenic compounds by GC–NCI–MS–MS; Curr. Trends Mass Spectrom. (May 2010) pp 10–15.
3. Macherone A., Derivatization Procedure and Negative Chemical Ionization GC/MS/MS Conditions for the Analysis of Steroidal Analogs; Agilent Technologies Application Note 5990-9478EN (2012).
4. Williard C., Application of GC/MS/MS in Monitoring Steroids as a Pharmacokinetic and Pharmacological Biomarker (2013).